Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — When used at moderate doses, the selective COX-2 inhibitor celecoxib was noninferior to the ...

Presenters noted that this was an important but unusual trial, because it examined drugs not in isolation but how they are used in combination. At the 2016 American Heart Association Scientific ...

Aug. 6, 2002 -- The cyclooxygenase (COX)-2 inhibitor celecoxib is safe for patients with aspirin-exacerbated respiratory disease (AERD), according to the results of a double-blind, placebo-controlled ...

NEW ORLEANS, LA — A long-awaited trial suggests the selective cyclooxygenase-2 (COX-2) inhibitor celecoxib has similar cardiovascular safety as naproxen and ibuprofen in arthritis patients at ...

NEW ORLEANS -- After 10 years during which 24,000 osteoarthritis (OA) and rheumatoid arthritis (RA) patients were randomized, the verdict on cardiovascular safety of NSAIDs is in and it's not all that ...

BARCELONA -- Relieving pain is essential to management of patients with rheumatoid or osteoarthritis, and NSAIDS are often the go-to first choice. But choosing the wrong NSAID can increase patients ...

Millions of people with arthritis take prescription-strength ibuprofen for pain relief, but a new study urges caution about this practice in light of data showing significant increases in blood ...

Barcelona, Spain - 28 Aug 2017: Ibuprofen is associated with increased blood pressure and hypertension compared to celecoxib in patients with osteoarthritis or rheumatoid arthritis and increased risk ...

Ibuprofen is associated with increased blood pressure and hypertension compared to celecoxib in patients with osteoarthritis or rheumatoid arthritis and increased risk of cardiovascular disease, ...